Dallas-Based Lantern Pharma is Going Public Jun 12 Written by Health Wildcatters Health Wildcatters Previous Previous Biotech startup Lantern Pharma’s IPO yields $26 million for its cancer drug development Next Next Dallas medical device startup looks to get people back on their feet